OOIR: Observatory of International Research

Papers

(The TQCC of JAMA Dermatology is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-09-01 to 2024-09-01.)

Article	Citations
Global Burden of Cutaneous Melanoma in 2020 and Projections to 2040	413
Efficacy and Safety of Upadacitinib vs Dupilumab in Adults With Moderate-to-Severe Atopic Dermatitis	282
Psoriasis Prevalence in Adults in the United States	218
Efficacy and Safety of Baricitinib Combined With Topical Corticosteroids for Treatment of Moderate to Severe Atopic Dermatitis	202
Lack of Transparency and Potential Bias in Artificial Intelligence Data Sets and Algorithms	144
Evaluation of Chilblains as a Manifestation of the COVID-19 Pandemic	115
Efficacy and Safety of Upadacitinib in Patients With Moderate to Severe Atopic Dermatitis	112
Delayed Localized Hypersensitivity Reactions to the Moderna COVID-19 Vaccine	107
Prevalence of Hidradenitis Suppurativa	107
Efficacy and Safety of Bimekizumab in Moderate to Severe Hidradenitis Suppurativa	99
Systemic Immunomodulatory Treatments for Atopic Dermatitis	93
Efficacy and Safety of Abrocitinib in Combination With Topical Therapy in Adolescents With Moderate-to-Severe Atopic Dermatitis	91
Checklist for Evaluation of Image-Based Artificial Intelligence Reports in Dermatology	87
Association Between Psoriasis and Nonalcoholic Fatty Liver Disease Among Outpatient US Adults	81
Clinical, Laboratory, and Interferon-Alpha Response Characteristics of Patients With Chilblain-like Lesions During the COVID-19 Pandemic	81
UBA1 Variations in Neutrophilic Dermatosis Skin Lesions of Patients With VEXAS Syndrome	75
Association of Cutaneous Immune-Related Adverse Events With Increased Survival in Patients Treated With Anti–Programmed Cell Death 1 and Anti–Programmed Cell Death Ligand 1 Therapy	74
Drug Survival Associated With Effectiveness and Safety of Treatment With Guselkumab, Ixekizumab, Secukinumab, Ustekinumab, and Adalimumab in Patients With Psoriasis	73
Investigation of Suicidality and Psychological Adverse Events in Patients Treated With Finasteride	67
UV Exposure and the Risk of Cutaneous Melanoma in Skin of Color	66
Association of Wildfire Air Pollution and Health Care Use for Atopic Dermatitis and Itch	66
Incidence of Cutaneous Reactions After Messenger RNA COVID-19 Vaccines	65
Long-term Efficacy of Baricitinib in Adults With Moderate to Severe Atopic Dermatitis Who Were Treatment Responders or Partial Responders	63
Dermatologist Perceptions of Teledermatology Implementation and Future Use After COVID-19	61
Assessment of Acute Acral Lesions in a Case Series of Children and Adolescents During the COVID-19 Pandemic	61

Association Between Early Severe Cardiovascular Events and the Initiation of Treatment With the Anti–Interleukin 12/23p40 Antibody Ustekinumab	60
Sirolimus (Rapamycin) for Slow-Flow Malformations in Children	60
Prognostic Gene Expression Profiling in Cutaneous Melanoma	58
Enanthem in Patients With COVID-19 and Skin Rash	58
Mucocutaneous Manifestations of Multisystem Inflammatory Syndrome in Children During the COVID-19 Pandemic	58
Insurance Acceptance, Appointment Wait Time, and Dermatologist Access Across Practice Types in the US	56
Association Between Atopic Eczema and Cancer in England and Denmark	54
Association Between Inflammatory Bowel Disease and Both Psoriasis and Psoriatic Arthritis	52
Association Between Short-term Exposure to Environmental Air Pollution and Psoriasis Flare	51
Association of Secukinumab Treatment With Tuberculosis Reactivation in Patients With Psoriasis, Psoriatic Arthritis, or Ankylosing Spondylitis	50
Rates of Vascular Occlusion Associated With Using Needles vs Cannulas for Filler Injection	50
Recurrence and Mortality Risk of Merkel Cell Carcinoma by Cancer Stage and Time From Diagnosis	50
Association Between Biologics Use and Risk of Serious Infection in Patients With Psoriasis	49
Association of Potent and Very Potent Topical Corticosteroids and the Risk of Osteoporosis and Major Osteoporotic Fractures	48
Incidence of Multiple vs First Cutaneous Squamous Cell Carcinoma on a Nationwide Scale and Estimation of Future Incidences of Cutaneous Squamous Cell Carcinoma	47
Prevalence of Vitiligo Among Adults in the United States	46
Efficacy and Safety of Lebrikizumab in Combination With Topical Corticosteroids in Adolescents and Adults With Moderate-to-Severe Atopic Dermatitis	45
Clinical Characteristics, Disease Course, and Outcomes of Patients With Acute Generalized Exanthematous Pustulosis in the US	42
Consensus Statement for the Management and Treatment of Port-Wine Birthmarks in Sturge-Weber Syndrome	42
Association Between Topical Calcineurin Inhibitor Use and Risk of Cancer, Including Lymphoma, Keratinocyte Carcinoma, and Melanoma	42
Clinical Characterization of Mogamulizumab-Associated Rash During Treatment of Mycosis Fungoides or Sézary Syndrome	42
Relative Efficacy of Minoxidil and the 5-α Reductase Inhibitors in Androgenetic Alopecia Treatment of Male Patients	41
Health-Related Quality of Life, Depression, and Self-esteem in Patients With Androgenetic Alopecia	40
Efficacy and Safety of Tralokinumab in Adolescents With Moderate to Severe Atopic Dermatitis	39
Assessment of Age, Period, and Birth Cohort Effects and Trends in Merkel Cell Carcinoma Incidence in the United States	39
Contribution of Genetics to the Susceptibility to Hidradenitis Suppurativa in a Large, Cross-sectional Dutch Twin Cohort	39
Identification of Biomarkers and Critical Evaluation of Biomarker Validation in Hidradenitis Suppurativa	38
Hidradenitis Suppurativa in the Pediatric Population	37
Patterns of Cutaneous and Noncutaneous Immune-Related Adverse Events Among Patients With Advanced Cancer	37
Surgical Interventions for Patients With Vitiligo	36
Association of Atopic Dermatitis and Mental Health Outcomes Across Childhood	36
Effect of Reflectance Confocal Microscopy for Suspect Lesions on Diagnostic Accuracy in Melanoma	36
Global Harmonization of Morphological Definitions in Hidradenitis Suppurativa for a Proposed Glossary	36
Long-term Persistence of First-line Biologics for Patients With Psoriasis and Psoriatic Arthritis in the French Health Insurance Database	35
Association of Risk of Incident Venous Thromboembolism With Atopic Dermatitis and Treatment With Janus Kinase Inhibitors	34
Livedoid and Purpuric Skin Eruptions Associated With Coagulopathy in Severe COVID-19	34
Effect of Risankizumab on Patient-Reported Outcomes in Moderate to Severe Psoriasis	34
Association Between Topical Calcineurin Inhibitor Use and Keratinocyte Carcinoma Risk Among Adults With Atopic Dermatitis	34
Use of Autologous Bacteriotherapy to Treat Staphylococcus aureus in Patients With Atopic Dermatitis	34
Effect of Different Itraconazole Dosing Regimens on Cure Rates, Treatment Duration, Safety, and Relapse Rates in Adult Patients With Tinea Corporis/Cruris	33
Five-Year Outcomes of a Melanoma Screening Initiative in a Large Health Care System	33
Tofacitinib for the Treatment of Nail Lesions and Palmoplantar Pustulosis in Synovitis, Acne, Pustulosis, Hyperostosis, and Osteitis Syndrome	32
Efficacy and Safety of Topical Timolol for the Treatment of Infantile Hemangioma in the Early Proliferative Stage	32
Assessment of Treatment Approaches and Outcomes in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis	32
Administrative Burden and Costs of Prior Authorizations in a Dermatology Department	32
Cost Minimization Analysis of a Teledermatology Triage System in a Managed Care Setting	31
Performance of Gene Expression Profile Tests for Prognosis in Patients With Localized Cutaneous Melanoma	31
Incidence and Prevalence of Granuloma Annulare in the United States	31
Association Between Melanoma Detected During Routine Skin Checks and Mortality	30
Bimekizumab Safety in Patients With Moderate to Severe Plaque Psoriasis	30

Association of Age, Sex, Race, and Geographic Region With Variation of the Ratio of Basal Cell to Cutaneous Squamous Cell Carcinomas in the United States	30
Machine Learning–Based Deep Phenotyping of Atopic Dermatitis	29
Assessing the Potential for Patient-led Surveillance After Treatment of Localized Melanoma (MEL-SELF)	29
Association of Lipid-Lowering Drugs With Risk of Psoriasis	29
Assessment of Changes in Diversity in Dermatology Clinical Trials Between 2010-2015 and 2015-2020	28
Assessment and Comparison of Performance of ABCD-10 and SCORTEN in Prognostication of Epidermal Necrolysis	28
Internet-Delivered Cognitive Behavior Therapy for Atopic Dermatitis	28
Efficiency of Detecting New Primary Melanoma Among Individuals Treated in a High-risk Clinic for Skin Surveillance	27
Assessment of Cutaneous Squamous Cell Carcinoma (cSCC) In situ Incidence and the Risk of Developing Invasive cSCC in Patients With Prior cSCC In situ vs the General Population in the Netherlands, 1989	27
Evaluation of Long-term Clearance Rates of Interventions for Actinic Keratosis	27
The Multidimensional Burden of Atopic Dermatitis Among Adults	27
Clinical Characteristics of Lupus Erythematosus Panniculitis/Profundus	27
Focus on “COVID Toes”	26
Consensus-Based Recommendations on the Prevention of Squamous Cell Carcinoma in Solid Organ Transplant Recipients	26
Association of Bullous Pemphigoid With Immune Checkpoint Inhibitor Therapy in Patients With Cancer	26
Epidemiologic Analysis of Chilblains Cohorts Before and During the COVID-19 Pandemic	26
Reactive Infectious Mucocutaneous Eruption Associated With SARS-CoV-2 Infection	26
Outcomes Following a Mandatory Nonmedical Switch From Adalimumab Originator to Adalimumab Biosimilars in Patients With Psoriasis	25
Patient-Reported Outcome Measures as Complementary Information to Clinician-Reported Outcome Measures in Patients With Psoriasis	25
Psoriasis Flares Following Systemic Glucocorticoid Exposure in Patients With a History of Psoriasis	25
Assessment and Treatment Outcomes of Persistent Radiation-Induced Alopecia in Patients With Cancer	25
The Genomic and Phenotypic Landscape of Ichthyosis	24
Estimating Overdiagnosis of Melanoma Using Trends Among Black and White Patients in the US	24
Association of Granuloma Annulare With Type 2 Diabetes, Hyperlipidemia, Autoimmune Disorders, and Hematologic Malignant Neoplasms	24
Inclusion of Older Adults in Randomized Clinical Trials for Systemic Medications for Atopic Dermatitis	24
Risk of Invasive Cutaneous Squamous Cell Carcinoma After Different Treatments for Actinic Keratosis	24
Trends in Prevalence and Incidence of Alopecia Areata, Alopecia Totalis, and Alopecia Universalis Among Adults and Children in a US Employer-Sponsored Insured Population	24
Evaluation of Site- and Autoantigen-Specific Characteristics of Mucous Membrane Pemphigoid	23
Efficacy and Safety of Topical Hypericin Photodynamic Therapy for Early-Stage Cutaneous T-Cell Lymphoma (Mycosis Fungoides)	23
Worldwide Prevalence of Antibiotic-Associated Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis	23
Long-term Outcomes and Prognosis in New-Onset Psoriasis	23
Ten-Year Follow-up of Persons With Sun-Damaged Skin Associated With Subsequent Development of Cutaneous Squamous Cell Carcinoma	23
Efficacy of Epigallocatechin-3-Gallate in Preventing Dermatitis in Patients With Breast Cancer Receiving Postoperative Radiotherapy	23
Clinical Features, Prognostic Factors, and Treatment Interventions for Ulceration in Patients With Infantile Hemangioma	23
Assessment of Diagnostic Performance of Dermatologists Cooperating With a Convolutional Neural Network in a Prospective Clinical Study	23
Association of Histologic Regression With a Favorable Outcome in Patients With Stage 1 and Stage 2 Cutaneous Melanoma	23
Dupilumab Drug Survival and Associated Predictors in Patients With Moderate to Severe Atopic Dermatitis	23
Association of Mohs Micrographic Surgery vs Wide Local Excision With Overall Survival Outcomes for Patients With Melanoma of the Trunk and Extremities	22
Prevalence and Odds of Depressive and Anxiety Disorders and Symptoms in Children and Adults With Alopecia Areata	22
Postmarketing Cases of Enfortumab Vedotin–Associated Skin Reactions Reported as Stevens-Johnson Syndrome or Toxic Epidermal Necrolysis	22
Drug Survival of Biologics in Patients With Hidradenitis Suppurativa	22
Association Between Surgical Margins Larger Than 1 cm and Overall Survival in Patients With Merkel Cell Carcinoma	22
Mycosis Fungoides in Children and Adolescents	22
Pregnancy Outcomes in Women With Moderate-to-Severe Psoriasis From the Psoriasis Longitudinal Assessment and Registry (PSOLAR)	22
Incidence of Venous Thromboembolism in Patients With Dermatologist-Diagnosed Chronic Inflammatory Skin Diseases	22
Incidence and Factors Associated With Acne Among Transgender Patients Receiving Masculinizing Hormone Therapy	21
Evaluation of Nomacopan for Treatment of Bullous Pemphigoid	21
Evaluation of Pharmacologic Treatments for H₁ Antihistamine–Refractory Chronic Spontaneous Urticaria	21
Assessment of Frequency of Rosacea Subtypes in Patients With Rosacea	21
Measuring Atopic Eczema Control and Itch Intensity in Clinical Practice	21
Association of Spironolactone Use With Risk of Cancer	21
Long-term Physical and Psychological Outcomes of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis	21
Treatment of Kimura Disease With Dupilumab	21
Tofacitinib as Treatment for Nail Lichen Planus Associated With Alopecia Universalis	20
Association of Clinical and Demographic Factors With the Severity of Palmoplantar Pustulosis	20
Association of Sun-Protective Behaviors With Bone Mineral Density and Osteoporotic Bone Fractures in US Adults	20
Assessment of Clinical Response to Anifrolumab in Patients With Refractory Discoid Lupus Erythematosus	20
Association of a Proposed New Staging System for Folliculotropic Mycosis Fungoides With Prognostic Variables in a US Cohort	20
Evaluation of Stigma Toward Individuals With Alopecia	20
Evaluation of the Use of Capecitabine for the Treatment and Prevention of Actinic Keratoses, Squamous Cell Carcinoma, and Basal Cell Carcinoma	20
Isotretinoin Laboratory Monitoring in Acne Treatment	20
Association of Patient Mental Health Status With the Level of Agreement Between Patient and Physician Ratings of Psoriasis Severity	20
Dermatologists’ Perspectives on Artificial Intelligence and Augmented Intelligence — A Cross-sectional Survey	20
Patient Perspectives on the Lived Experience of Acne and Its Treatment Among Adult Women With Acne	19
Epidermolysis Bullosa Pruriginosa Treated With Baricitinib	19
Patient-Reported Outcome Measures for Health-Related Quality of Life in Patients With Acne Vulgaris	19
Assessment of Diagnostic Accuracy of Dermoscopic Structures and Patterns Used in Melanoma Detection	19
Association of Atopic Dermatitis Severity With Learning Disability in Children	19
Differences Between Children and Adults With Hidradenitis Suppurativa	19
Safety and Efficacy of VP-102, a Proprietary, Drug-Device Combination Product Containing Cantharidin, 0.7% (w/v), in Children and Adults With Molluscum Contagiosum	19
Efficacy and Safety of Upadacitinib Treatment in Adolescents With Moderate-to-Severe Atopic Dermatitis	19
Allergic Contact Dermatitis	18
Sebaceous Carcinoma Incidence and Survival Among Solid Organ Transplant Recipients in the United States, 1987-2017	18
Mixed Individual-Aggregate Data on All-Cause Mortality in Bullous Pemphigoid	18
Improvement of Mortality Prognostication in Patients With Epidermal Necrolysis	18
Molecular and Clinical Outcomes After Intravenous Gentamicin Treatment for Patients With Junctional Epidermolysis Bullosa Caused by Nonsense Variants	18
Evaluation of a Case Series of Patients With Generalized Pustular Psoriasis in the United States	18
Validation of Psychometric Properties of the Itch Numeric Rating Scale for Pruritus Associated With Prurigo Nodularis	18
Long-term Efficacy and Safety of Up to 108 Weeks of Ixekizumab in Pediatric Patients With Moderate to Severe Plaque Psoriasis	18
Association of Apremilast With Vascular Inflammation and Cardiometabolic Function in Patients With Psoriasis	18

Melanoma and Racial Health Disparities in Black Individuals—Facts, Fallacies, and Fixes	18
Association of Patient Risk Factors, Tumor Characteristics, and Treatment Modality With Poor Outcomes in Primary Cutaneous Squamous Cell Carcinoma	18
Granulomatous Dermatitis Associated With Rubella Virus Infection in an Adult With Immunodeficiency	17
An Evaluation of the Performance of Current Morphea Subtype Classifications	17
Pain Severity and Management of Hidradenitis Suppurativa at US Emergency Department Visits	17
Clinicopathologic Characteristics and Response to Treatment of Persistent Chemotherapy-Induced Alopecia in Breast Cancer Survivors	17
Association of Persistent Rubella Virus With Idiopathic Skin Granulomas in Clinically Immunocompetent Adults	17
Randomized Trial Replication Using Observational Data for Comparative Effectiveness of Secukinumab and Ustekinumab in Psoriasis	17
Analysis of Specialist and Patient Perspectives on Strategies to Improve Cardiovascular Disease Prevention Among Persons With Psoriatic Disease	17
A Global eDelphi Exercise to Identify Core Domains and Domain Items for the Development of a Global Registry of Alopecia Areata Disease Severity and Treatment Safety (GRASS)	17
Treatment of Oral Erosive Lichen Planus With Upadacitinib	17
Association Between Atopic Dermatitis and Educational Attainment in Denmark	17
A Mutational Survey of Acral Nevi	17
The Risk of Anal Carcinoma After Anogenital Warts in Adults Living With HIV	16
Evaluation of the Safety and Effectiveness of Nutritional Supplements for Treating Hair Loss	16
Understanding Flares in Patients With Generalized Pustular Psoriasis Documented in US Electronic Health Records	16
Association of Sensorineural Hearing Loss in Patients With Alopecia Areata	16
Central Centrifugal Cicatricial Alopecia	16
Evaluation of Watchful Waiting and Tumor Behavior in Patients With Basal Cell Carcinoma	16
Clinically Applicable Deep Learning Framework for Measurement of the Extent of Hair Loss in Patients With Alopecia Areata	16
Assessment of Diagnostic Strategy for Mucous Membrane Pemphigoid	16
Association of Facial Pustular Neutrophilic Eruption With Messenger RNA–1273 SARS-CoV-2 Vaccine	16
Association of Psoriasis With Incident Venous Thromboembolism and Peripheral Vascular Disease	16
Trends of Research Output of Allopathic Medical Students Matching Into Dermatology, 2007-2018	16
Evaluation of a Comprehensive Skin Toxicity Program for Patients Treated With Epidermal Growth Factor Receptor Inhibitors at a Cancer Treatment Center	16
Comorbidities of Keloid and Hypertrophic Scars Among Participants in UK Biobank	15
Mental Health and Psychosocial Quality-of-Life Burden Among Patients With Vitiligo	15
International eDelphi Study to Reach Consensus on the Methotrexate Dosing Regimen in Patients With Psoriasis	15
Effectiveness and Safety of Systemic Therapy for Psoriasis in Older Adults	15
Shared Decision-making in Dermatology	15
Keloids	15
Trends in the Prevalence of Methylchloroisothiazolinone/Methylisothiazolinone Contact Allergy in North America and Europe	15
Clinical and Dermoscopic Features of Vulvar Melanosis Over the Last 20 Years	15
FrontlineBRAFTesting–Guided Treatment for Advanced Melanoma in the Era of Immunotherapies	15
Implications of Satellitosis or In-transit Metastasis in Cutaneous Squamous Cell Carcinoma	14
Long-term Outcomes After Rituximab Treatment for Patients With Systemic Sclerosis	14
Treatment of Persistent Erythema Multiforme With Janus Kinase Inhibition and the Role of Interferon Gamma and Interleukin 15 in Its Pathogenesis	14
A Practical Approach to the Management of Digital Ulcers in Patients With Systemic Sclerosis	14
Association Between Atopic Dermatitis and Height, Body Mass Index, and Weight in Children	14
An Approach to Examining Tightly Coiled Hair Among Patients With Hair Loss in Race-Discordant Patient-Physician Interactions	14
Risk of Mortality After a Diagnosis of Melanoma In Situ	14
Evaluation and Comparison of Clinical and iLaboratory Characteristics of Patients With IgA Epidermolysis Bullosa Acquisita, Linear IgA Bullous Dermatosis, and IgG Epidermolysis Bullosa Acquisita	14
Inflation-Adjusted Trends in Medicare Reimbursement for Common Dermatologic Procedures, 2007-2021	14
Effect of Costimulatory Blockade With Abatacept After Ustekinumab Withdrawal in Patients With Moderate to Severe Plaque Psoriasis	14
Moderate-to-Severe Acne and Mental Health Symptoms in Transmasculine Persons Who Have Received Testosterone	14
Risks of Multiple Skin Cancers in Organ Transplant Recipients	14
Risk of All-Cause Mortality, Cardiovascular Disease Mortality, and Cancer Mortality in Patients With Bullous Pemphigoid	14
Quality and Perceived Usefulness of Patient-Submitted Store-and-Forward Teledermatology Images	14
Values and Preferences of Patients and Caregivers Regarding Treatment of Atopic Dermatitis (Eczema)	13
Association of Anti–Programmed Cell Death 1 Antibody Treatment With Risk of Recurrence of Toxic Effects After Immune-Related Adverse Events of Ipilimumab in Patients With Metastatic Melanoma	13
Quality of Life Assessed Using Skindex-16 Scores Among Patients With Acne Receiving Isotretinoin Treatment	13
Validity of Using Billing Codes From Electronic Health Records to Estimate Skin Cancer Counts	13
Early Detection and Prognostic Assessment of Cutaneous Melanoma	13
Patient Impressions and Outcomes After Clinic-Based Hidradenitis Suppurativa Surgery	13
Topical Corticosteroids and Glucocorticoid-Induced Osteoporosis—Cumulative Dose and Duration Matter	13
Differences in Merkel Cell Carcinoma Presentation and Outcomes Among Racial and Ethnic Groups	13
Evaluation of the Prevalence and Incidence of Pediatric Alopecia Areata Using Electronic Health Record Data	13
Risk Factors for the Development of Bullous Pemphigoid in US Patients Receiving Immune Checkpoint Inhibitors	13
Brentuximab Vedotin for Relapsed or Refractory Sézary Syndrome	13
Evidence-Based Clinical Practice Guidelines for Laser-Assisted Drug Delivery	13
Evaluation of Risk of Bullous Pemphigoid With Initiation of Dipeptidyl Peptidase–4 Inhibitor vs Second-generation Sulfonylurea	13
Safety and Efficacy of Tralokinumab in Older Adults With Moderate-to-Severe Atopic Dermatitis	13
Mapping of Segmental and Partial Segmental Infantile Hemangiomas of the Face and Scalp	13
Safety and Efficacy of Topical Lovastatin Plus Cholesterol Cream vs Topical Lovastatin Cream Alone for the Treatment of Disseminated Superficial Actinic Porokeratosis	13
Legislative Efforts Restricting Care for Transgender People	13
Treatment of Severe Nail Lichen Planus With Baricitinib	12
Risk of Bias and Error From Data Sets Used for Dermatologic Artificial Intelligence	12
Shared Decision-Making, Therapeutic Choice, and Decisional Regret in Patients With Alopecia Areata	12
Real-time Analysis of Skin Biopsy Specimens With 2-Photon Fluorescence Microscopy	12
Antibiotic Stewardship in Dermatology—Reducing the Risk of Prolonged Antimicrobial Resistance in Skin	12
Treatment With Anifrolumab for Discoid Lupus Erythematosus	12
Skin Cancer Risk Factors and Screening Among Asian American Individuals	12
Spectrum of Nonkeratinocyte Skin Cancer Risk Among Solid Organ Transplant Recipients in the US	12
Dupilumab-Associated Lymphoid Reactions in Patients With Atopic Dermatitis	12
Prurigo Nodularis	12
Pigmented Fungiform Papillae of the Tongue	12
Evaluation of Systemic Gentamicin as Translational Readthrough Therapy for a Patient With Epidermolysis Bullosa Simplex With Muscular Dystrophy Owing to PLEC1 Pathogenic Nonsense Variants	12
Treatment of Grover Disease With Dupilumab	12
Cardiovascular and Venous Thromboembolic Risk With JAK Inhibitors in Immune-Mediated Inflammatory Skin Diseases	12
Evaluation of Dupilumab in Patients With Bullous Pemphigoid	12
Out-of-Pocket Costs of Specialty Medications for Psoriasis and Psoriatic Arthritis Treatment in the Medicare Population	11
Resisting Racism in Dermatology	11
Risks of Comorbidities in Patients With Palmoplantar Pustulosis vs Patients With Psoriasis Vulgaris or Pompholyx in Korea	11
Homozygous MEFV Gene Variant and Pyrin-Associated Autoinflammation With Neutrophilic Dermatosis	11
Sentinel Lymph Node Biopsy Positivity in Patients With Acral Lentiginous and Other Subtypes of Cutaneous Melanoma	11
Evaluation of a Case Series of Patients With Palmoplantar Pustulosis in the United States	11
Bullous and Exanthematous Lesions Associated With Chimeric Antigen Receptor T-Cell Therapy in a Patient With Diffuse Large B-Cell Lymphoma	11
Cutaneous T-Cell–Rich Lymphoid Infiltrates After SARS-CoV-2 Vaccination	11
Vitiligo	11
Improvement of Chronic Kidney Disease–Associated Pruritus After Treatment With Intravenous Naloxone	11
Multivariable Predictive Models to Identify the Optimal Biologic Therapy for Treatment of Patients With Psoriasis at the Individual Level	11
Clinical and Pathological Characteristics and Outcomes Among Patients With Subcutaneous Panniculitis-like T-Cell Lymphoma and Related Adipotropic Lymphoproliferative Disorders	11
Treatment Outcomes Associated With Dupilumab Use in Patients With Atopic Dermatitis	11
Treatment of Livedoid Vasculopathy With Baricitinib	11
Differences in Outpatient Dermatology Encounter Work Relative Value Units and Net Payments by Patient Race, Sex, and Age	11